Isogenica is at the forefront of synthetic biology, pursuing a mission to provide the fastest, most efficient engine for therapeutic antibody discoveryRead More
Vienna, Austria | 25th March–27th 2019 Isogenica is excited to be attending Bio-Europe this year.
London, UK | 24th-25th April 2019
Isogenica will be speaking about VHH single domain antibodies generated from our LlamdA library.
Cambridge, UK 21st January 2019
Isogenica LlamdA VHH antibodies reported as a potential treatment.
Cambridge, UK, 7th January 2019
Today, Isogenica have announced an expansion of the collaboration and license agreement signed with Aro Biotherapeutics